CLASS II Drug recall · Reported 20 Sep 2017 · FDA Enforcement Report

Paroxetine tablets USP, 30mg recalled by Zydus Pharmaceuticals USA

Zydus Pharmaceuticals USA is recalling Paroxetine tablets USP, 30mg, distributed nationwide in the US. The recall was initiated on 18 Aug 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot #: Z701133, Exp 03/19
NDC68382-001, 68382-097, 68382-098, 68382-099
UPC0368382098108, 0368382099105, 368382099068
Quantity recalled44800 bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-1137-2017
FDA event ID
77963
Recalling firm
Zydus Pharmaceuticals USA, Pennington, NJ
Manufacturer
Zydus Pharmaceuticals USA Inc.
Classification
Class II
Status
Terminated
Recall initiated
18 Aug 2017
FDA classified
11 Sep 2017
Reported
20 Sep 2017
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Other Reasons
Drug class
Antidepressants

Timeline

18 Aug 2017Recall initiated by company
11 Sep 2017Classified by FDA+24 days
20 Sep 2017Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Product as listed by the FDA

Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8

Where it was distributed

Nationwide within United States

Nationwide

Questions about this recall

Is Paroxetine tablets USP, 30mg recalled?

Yes. Zydus Pharmaceuticals USA recalled Paroxetine tablets USP, 30mg on 18 Aug 2017. The recall is Class II and its status is Terminated. Recall number D-1137-2017.

Why was it recalled?

Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets

Which lots are affected?

Lot #: Z701133, Exp 03/19

Where was it sold?

Nationwide within United States

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Zydus Pharmaceuticals USA

All 95

Other Paroxetine recalls

All 16